Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of necroptosis in kidney health and disease
Benedikt Kolbrink, Friedrich Alexander von Samson‐Himmelstjerna, James M. Murphy, et al.
Nature Reviews Nephrology (2023) Vol. 19, Iss. 5, pp. 300-314
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Regulated cell death pathways in kidney disease
Ana B. Sanz, María Dolores Sánchez-Niño, Adrián M. Ramos, et al.
Nature Reviews Nephrology (2023) Vol. 19, Iss. 5, pp. 281-299
Open Access | Times Cited: 134
Typhaneoside-Tetrahedral Framework Nucleic Acids System: Mitochondrial Recovery and Antioxidation for Acute Kidney Injury treatment
Ran Yan, Weitong Cui, Wenjuan Ma, et al.
ACS Nano (2023) Vol. 17, Iss. 9, pp. 8767-8781
Closed Access | Times Cited: 70
Ferroptosis, Necroptosis, and Pyroptosis in Gastrointestinal Cancers: The Chief Culprits of Tumor Progression and Drug Resistance
Xudong Zhu, Shenglong Li
Advanced Science (2023) Vol. 10, Iss. 26
Open Access | Times Cited: 42
Mediators of necroptosis: from cell death to metabolic regulation
Xiaoqin Wu, Laura E. Nagy, Jérémie Gautheron
EMBO Molecular Medicine (2024) Vol. 16, Iss. 2, pp. 219-237
Open Access | Times Cited: 14
Metformin potentiates nephrotoxicity by promoting NETosis in response to renal ferroptosis
Zhaoxian Cai, Xiaotian Wu, Zijun Song, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 29
The emerging role of regulated cell death in ischemia and reperfusion-induced acute kidney injury: current evidence and future perspectives
Chenning Li, Ying Yu, Shuainan Zhu, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Protein phosphorylation and kinases: Potential therapeutic targets in necroptosis
Yihui Shi, Chengkun Wu, Jiayi Shi, et al.
European Journal of Pharmacology (2024) Vol. 970, pp. 176508-176508
Closed Access | Times Cited: 6
Xanthohumol attenuates TXNIP-mediated renal tubular injury in vitro and in vivo diabetic models
Yan Zhang, Runzhou Pan, Shou Zhang, et al.
Journal of Natural Medicines (2025)
Closed Access
Noncoding RNAs in sepsis-associated acute liver injury: Roles, mechanisms, and therapeutic applications
Jialian Wang, Xingyu Tao, Zhengyang Liu, et al.
Pharmacological Research (2025) Vol. 212, pp. 107596-107596
Open Access
Emerging role of PANoptosis in kidney diseases: molecular mechanisms and therapeutic opportunities
Yiping Hou, Qi Feng, C. C. Wei, et al.
APOPTOSIS (2025)
Closed Access
Necroptosis contributes to non-alcoholic fatty liver disease pathoetiology with promising diagnostic and therapeutic functions
Hong-Ju Sun, Bo Jiao, Yan Wang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 14, pp. 1968-1981
Open Access | Times Cited: 5
Cell death pathways: molecular mechanisms and therapeutic targets for cancer
Shaohui Wang, Sa Guo, Jing Guo, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 5
Spotlight on necroptosis: Role in pathogenesis and therapeutic potential of intervertebral disc degeneration
Rui Ran, Shun-Bai Zhang, Yong-Qiang Shi, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112616-112616
Closed Access | Times Cited: 4
Neutrophil‐Mediated Nanozyme Delivery System for Acute Kidney Injury Therapy
Yang Yu, Jiang Du, Jingjing Gan, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 3
Podocyte programmed cell death in diabetic kidney disease: Molecular mechanisms and therapeutic prospects
Haoyu Yang, Jun Sun, Aru Sun, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117140-117140
Closed Access | Times Cited: 3
Dynamics of necroptosis in kidney ischemia-reperfusion injury
Aspasia Pefanis, Anjan K. Bongoni, Jennifer L. McRae, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Regulated necrosis role in inflammation and repair in acute kidney injury
Juan Guerrero‐Mauvecin, Natalia Villar-Gómez, Sandra Rayego‐Mateos, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Cell death induced by acute renal injury: a perspective on the contributions of accidental and programmed cell death
Mi Ra Noh, Babu J. Padanilam
AJP Renal Physiology (2024) Vol. 327, Iss. 1, pp. F4-F20
Closed Access | Times Cited: 2
Ultrasmall Nanodots with Dual Anti‐Ferropototic Effect for Acute Kidney Injury Therapy
Fantian Zeng, Yatong Qin, Sureya Nijiati, et al.
Advanced Science (2024) Vol. 11, Iss. 39
Open Access | Times Cited: 2
Research hotspots and future trends in lipid metabolism in chronic kidney disease: a bibliometric and visualization analysis from 2004 to 2023
Ying Wang, Tongtong Liu, Weijing Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization
Yanxiang Meng, Sarah E. Garnish, Katherine A. Davies, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase
Catia L. Pierotti, Annette V. Jacobsen, Christoph Grohmann, et al.
Biochemical Journal (2023) Vol. 480, Iss. 9, pp. 665-684
Open Access | Times Cited: 6
A network pharmacological-based study of the mechanism of Liuwei Dihuang pill in the treatment of chronic kidney disease
Xi Xie, Hongjun Lou, Ye Shi, et al.
Medicine (2023) Vol. 102, Iss. 19, pp. e33727-e33727
Open Access | Times Cited: 5
Mitochondrial fumarate promotes ischemia/reperfusion‐induced tubular injury
Zuo‐Lin Li, Ming‐Min Huang, Meng‐Yao Yu, et al.
Acta Physiologica (2024) Vol. 240, Iss. 4
Closed Access | Times Cited: 1
Non-Apoptotic Programmed Cell Death as Targets for Diabetic Retinal Neurodegeneration
Yingjia Lin, Shuping Ke, Weiqing Ye, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 837-837
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top